These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 17306906
1. A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan. Chen YM, Perng RP, Shih JF, Tsai CM, Whang-Peng J. Lung Cancer; 2007 Jun; 56(3):363-9. PubMed ID: 17306906 [Abstract] [Full Text] [Related]
4. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. Fossella F, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, Kaukel E, Mattson KV, Ramlau R, Szczesna A, Fidias P, Millward M, Belani CP. J Clin Oncol; 2003 Aug 15; 21(16):3016-24. PubMed ID: 12837811 [Abstract] [Full Text] [Related]
7. A Phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly. Chen YM, Perng RP, Tsai CM, Whang-Peng J. J Thorac Oncol; 2006 Feb 15; 1(2):141-5. PubMed ID: 17409843 [Abstract] [Full Text] [Related]
8. Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial. Belani CP, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, Kaukel E, Mattson KV, Ramlau R, Szczesna A, Fidias P, Millward M, Fossella F, TAX 326 study group. Lung Cancer; 2006 Aug 15; 53(2):231-9. PubMed ID: 16787687 [Abstract] [Full Text] [Related]
13. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis. Le Chevalier T, Pujol JL, Douillard JY, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Besson F. Semin Oncol; 1994 Oct 15; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766 [Abstract] [Full Text] [Related]
14. Docetaxel vs. vinorelbine in elderly patients with advanced non--small-cell lung cancer: a hellenic oncology research group randomized phase III study. Karampeazis A, Vamvakas L, Agelidou A, Kentepozidis N, Chainis K, Chandrinos V, Vardakis N, Pallis AG, Christophyllakis C, Georgoulias V. Clin Lung Cancer; 2011 May 15; 12(3):155-60. PubMed ID: 21663857 [Abstract] [Full Text] [Related]
15. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Zatloukal P, Petruzelka L, Zemanova M, Havel L, Janku F, Judas L, Kubik A, Krepela E, Fiala P, Pecen L. Lung Cancer; 2004 Oct 15; 46(1):87-98. PubMed ID: 15364136 [Abstract] [Full Text] [Related]
16. Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: a randomized, multicenter phase III trial. Georgoulias V, Ardavanis A, Agelidou A, Agelidou M, Chandrinos V, Tsaroucha E, Toumbis M, Kouroussis C, Syrigos K, Polyzos A, Samaras N, Papakotoulas P, Christofilakis C, Ziras N, Alegakis A. J Clin Oncol; 2004 Jul 01; 22(13):2602-9. PubMed ID: 15226327 [Abstract] [Full Text] [Related]
19. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer. Yasuda H, Yamaya M, Nakayama K, Sasaki T, Ebihara S, Kanda A, Asada M, Inoue D, Suzuki T, Okazaki T, Takahashi H, Yoshida M, Kaneta T, Ishizawa K, Yamanda S, Tomita N, Yamasaki M, Kikuchi A, Kubo H, Sasaki H. J Clin Oncol; 2006 Feb 01; 24(4):688-94. PubMed ID: 16446342 [Abstract] [Full Text] [Related]